den nächsten Monaten und Jahren noch mindestens 582,052,632 Anteile kommen;
291,000,000 als Aktienoptionen und 291,052,632 Anteile in Folge der Umwandlung der verbliebenen 2,765 Series C Anteile. Also insgesamt wird dann (ohne neue Aktien Ausgaben) die Aktienzahl auf 6,310,012,289 belaufen. Die Zahl der Series C Anteile wurde (siehe unten) im Jahr zwischen 31.03.2025 und 31.03.2026 von 6,651 auf 2,765 deutlich reduziert.
"The total potential common shares as of March 31, 2026, include 291,000,000 stock options and 291,052,632 common shares issuable upon conversion of the outstanding 2,765 Series C Preferred shares. Stock options and common shares issuable upon conversion of Series C Preferred shares were not included in the calculation of net earnings per share because their impact on income per share is antidilutive.
The total potential common shares as of March 31, 2025, include 534,965,911 stock options, 78,095,239 common stock purchase warrants, and 700,105,263 common shares issuable upon conversion of the outstanding 6,651 Series C Preferred shares. Stock options, common stock purchase warrants, and common shares issuable upon conversion of Series C Preferred shares were not included in the calculation of net earnings per share because their impact on income per share is antidilutive."